PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
09-Jul-2025 Phesi CEO warns phase 3 trial failures loom as sponsors overlook real-world data and overcrowd investigator sites Phesi
09-Jul-2025 Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy Actithera
08-Jul-2025 SMC recommends Eladynos®▼ (abaloparatide) for treating osteoporosis in postmenopausal women Theramex
08-Jul-2025 The Scottish Medicines Consortium (SMC) has announced that following a Fast Track Resubmission by Eisai, Leqembi® (lecanemab) has not been recommended for use in the National Health Service (NHS) in Scotland1 Eisai
08-Jul-2025 Ciloa secures €6.5 million government funding from France 2030 ‘Innovation in biotherapies and biomanufacturing’ to develop drug candidate for treatment of obesity and type 2 diabetes Andrew Lloyd Associates
08-Jul-2025 UCB presents latest research advancements at European Pediatric Neurology Society Congress UCB
08-Jul-2025 Oncopeptides’ drug Pepaxti included in European Guidelines for the treatment of multiple myeloma Oncopeptides
08-Jul-2025 Hyaluronic Acid Dermal Filler Market Poised to Surpass USD 10.8 Billion by 2033 Amid Rising Demand for Minimally Invasive Aesthetic Treatments Ameco Research
07-Jul-2025 Tendonitis Treatment Market Crosses USD 223.7 Billion in 2024, Set to Surge Beyond USD 308 Billion by 2033 with Advancements in Regenerative Therapies Acumen Research and Consulting
07-Jul-2025 Biocon Biologics Receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars Biocon Biologics
04-Jul-2025 Calcium Phosphate Bone Cement Market Set to Reach USD 1.33 Bn by 2033, Rising 5.6% CAGR on Surge in Minimally Invasive and Regenerative Orthopaedic Practices Ameco Research
04-Jul-2025 CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research CD Bioparticles
04-Jul-2025 CD Bioparticles Launches Advanced Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles for Targeted Cancer Therapy CD Bioparticles
04-Jul-2025 Creative Diagnostics Launches Human Hybrid IgM Control Monoclonal Antibodies to Accelerate Diagnostic Assay Development Creative Diagnostics
04-Jul-2025 Creative Diagnostics Announces Advanced Microbial Genome Editing Services to Accelerate Bio-research Creative Diagnostics
03-Jul-2025 Enthesopathy Treatment Market Set for Explosive Growth to $337.5 Billion by 2033 amid Surge in Biologics and Regenerative Therapies – A Report By Acumen Research And Consulting Acumen Research and Consulting
03-Jul-2025 VIVEbiotech Appoints Patricio Massera as President VIVEbiotech
03-Jul-2025 Advancing Bone Health: European Commission Approves Biocon Biologics’ Denosumab Biosimilars Biocon Biologics
03-Jul-2025 First Patient Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Haemophilia B in Germany CSL Behring
03-Jul-2025 HUTCHMED to Announce 2025 Half-Year Financial Results HUTCHMED